Related Experiment Video
Updated: Mar 12, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-134 functions as a tumor suppressor gene in gastric cancer
1Nursing School, Central South UniversityNo. 172 Tongzipo Road, Yuelu District, Changsha 410013, Hunan Province, China; Guiyang Nursing Vocational CollegeNo. 2 Stone Forest Road, Mountain Lakes District, Guiyang 550023, Guizhou Province, China.
Abstract:
MiR-134 can function as an oncogene or a tumor suppressor gene depending on cell type. However, the function of miR-134 in gastric cancer remains unclear to date. This study aims to evaluate the function of miR-134 in gastric cancer and investigate its effect on the sensitivity of gastric cancer cells to 5-FU. The expression of miR-134 assayed by real-time PCR was significantly lower in gastric cancer tissues than in noncancerous tissues. Over-expression of miR-134 significantly inhibited the proliferation and growth in vivo, as well as promoted the apoptosis of gastric cancer cells by targeting KRAS. Finally, the up-regulation of miR-134 enhanced the sensitivity of gastric cancer cells to 5-FU. In conclusion, miR-134 suppresses tumor development in gastric cancer by targeting KRAS and enhances cell sensitivity to 5-FU. Our results encourage researchers to use 5-FU in combination with miR-134 to treat gastric cancer.
Insights
MicroRNA-134 (miR-134) acts as a tumor suppressor in gastric cancer by inhibiting KRAS. Upregulating miR-134 increases sensitivity to 5-fluorouracil (5-FU) chemotherapy, suggesting a potential combination therapy.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNA-134 (miR-134) has dual roles as an oncogene or tumor suppressor, but its function in gastric cancer is not well understood.
- The role of miR-134 in gastric cancer development and its impact on chemotherapy sensitivity require further investigation.
Purpose of the Study:
- To elucidate the function of miR-134 in gastric cancer.
- To determine the effect of miR-134 on the sensitivity of gastric cancer cells to 5-fluorouracil (5-FU).
Main Methods:
- Quantitative real-time PCR was used to assess miR-134 expression levels in gastric cancer tissues.
- In vivo studies were conducted to evaluate the effects of miR-134 overexpression on tumor growth and apoptosis.
- The molecular target of miR-134 was identified as KRAS.
Main Results:
- miR-134 expression was significantly downregulated in gastric cancer tissues compared to noncancerous tissues.
- Overexpression of miR-134 suppressed gastric cancer cell proliferation and growth in vivo.
- miR-134 overexpression promoted apoptosis in gastric cancer cells by targeting KRAS.
- Upregulation of miR-134 enhanced the sensitivity of gastric cancer cells to 5-FU.
Conclusions:
- miR-134 functions as a tumor suppressor in gastric cancer by targeting KRAS.
- miR-134 enhances the sensitivity of gastric cancer cells to 5-FU, indicating its potential as a therapeutic target.
- Combining 5-FU with miR-134 may represent a promising strategy for gastric cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Experimental RNAi
Abnormal Proliferation

